Sign up to save your podcasts
Or
Share Repurposing loperamide to target glioma, metabolic reprogramming, liquid biopsies.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Repurposing loperamide to target glioma, metabolic reprogramming, liquid biopsies.
In this episode, recorded just before the New Year, I discuss recent news in brain cancer research.
This includes:
How the drug loperamide (brand name Imodium), induces cell death in glioblastoma cell lines and if this could have promise for real, human applications.
Metabolic reprogramming via inhibition of a key cancer metabolite- D-2-Hydroxyglutarate (D-2-HG).
Developments of liquid biopsies for glioma.
View all episodes
By Andrew Scarborough
5
44 ratings
In this episode, recorded just before the New Year, I discuss recent news in brain cancer research.
This includes:
How the drug loperamide (brand name Imodium), induces cell death in glioblastoma cell lines and if this could have promise for real, human applications.
Metabolic reprogramming via inhibition of a key cancer metabolite- D-2-Hydroxyglutarate (D-2-HG).
Developments of liquid biopsies for glioma.